These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1175 related articles for article (PubMed ID: 18644444)
41. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718 [TBL] [Abstract][Full Text] [Related]
42. Properties and active substance release kinetics from gelatin-alginate matrices. Pluta J; Haznar D Polim Med; 2006; 36(3):55-69. PubMed ID: 17190292 [TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery. Sheshala R; Peh KK; Darwis Y Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637 [TBL] [Abstract][Full Text] [Related]
44. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats. Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501 [TBL] [Abstract][Full Text] [Related]
45. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Liu J; Gong T; Wang C; Zhong Z; Zhang Z Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of sodium alginate as drug release modifier in matrix tablets. Liew CV; Chan LW; Ching AL; Heng PW Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576 [TBL] [Abstract][Full Text] [Related]
47. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules. Pal D; Nayak AK AAPS PharmSciTech; 2011 Dec; 12(4):1431-41. PubMed ID: 22038475 [TBL] [Abstract][Full Text] [Related]
48. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Chatchawalsaisin J; Podczeck F; Newton JM Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137 [TBL] [Abstract][Full Text] [Related]
49. Effect of preparation conditions on the nutrient release properties of alginate-whey protein granular microspheres. Chen L; Subirade M Eur J Pharm Biopharm; 2007 Mar; 65(3):354-62. PubMed ID: 17150342 [TBL] [Abstract][Full Text] [Related]
50. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats. Onishi H; Koyama K; Sakata O; Machida Y Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284 [TBL] [Abstract][Full Text] [Related]
51. A novel system for three-pulse drug release based on "tablets in capsule" device. Li B; Zhu J; Zheng C; Gong W Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142 [TBL] [Abstract][Full Text] [Related]
52. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery. Kumar A; Lahiri SS; Singh H Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246 [TBL] [Abstract][Full Text] [Related]
53. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials. Kim MS; Park GD; Jun SW; Lee S; Park JS; Hwang SJ J Pharm Pharmacol; 2005 Dec; 57(12):1521-8. PubMed ID: 16354396 [TBL] [Abstract][Full Text] [Related]
54. Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying. Möbus K; Siepmann J; Bodmeier R Eur J Pharm Biopharm; 2012 May; 81(1):121-30. PubMed ID: 22342605 [TBL] [Abstract][Full Text] [Related]
55. SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats. Nnamani PO; Attama AA; Ibezim EC; Adikwu MU Eur J Pharm Biopharm; 2010 Sep; 76(1):68-74. PubMed ID: 20554020 [TBL] [Abstract][Full Text] [Related]
56. Effect of manufacturing parameters on the release profiles of casein-loaded alginate microspheres prepared by emulsification/internal gelation. Li R; Zhang X; Shi H J Control Release; 2011 Nov; 152 Suppl 1():e154-5. PubMed ID: 22195817 [No Abstract] [Full Text] [Related]
57. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen. Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813 [TBL] [Abstract][Full Text] [Related]
58. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique. Wells LA; Sheardown H Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984 [TBL] [Abstract][Full Text] [Related]
59. Nanoparticulate assembly of mannuronic acid- and guluronic acid-rich alginate: oral insulin carrier and glucose binder. Kadir A; Mokhtar MT; Wong TW J Pharm Sci; 2013 Dec; 102(12):4353-63. PubMed ID: 24258282 [TBL] [Abstract][Full Text] [Related]
60. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]